Hedge Fund VC Activity Reveals Biopharma's Fading Momentum | Institutional Investor

Retrieved on: 2025-08-05 18:41:38

Tags for this article:

Click the tags to see associated articles and topics

Hedge Fund VC Activity Reveals Biopharma's Fading Momentum | Institutional Investor. View article details on hiswai:

Excerpt

Venture capital activity in the biopharma and life sciences industries has significantly declined from last year's near-record pace.

Article found on: www.institutionalinvestor.com